Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.94
-0.5800-1.90%
Post-market: 29.81-0.1216-0.41%19:30 EDT
Volume:5K
Turnover:145.87K
Market Cap:31.43M
PE:- -
High:30.40
Open:30.40
Low:29.81
Close:30.52
52wk High:33.59
52wk Low:23.00
Shares:1.05M
Float Shares:1.05M
Volume Ratio:0.18
T/O Rate:0.46%
Dividend:0.07
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

True Health Medical Surges Over 14% to a Record High, Driving AI and Digital Healthcare Expansion

Deep News
·
Aug 05

Top IQVIA Execs Quietly Cash In on Major Stock Move

TIPRANKS
·
Aug 05

Hinge Health Posts Record Q2 Results, Raises Outlook

TIPRANKS
·
Aug 05

IQVIA President MedTech and Consumer Health Bhavik Patel Sells 1,855 Shares for $436,927.85

Reuters
·
Aug 05

IQVIA Partners with Medera to Advance Cardiac Gene Therapy Development

Reuters
·
Aug 05

DexCom Director Mark G. Foletta Disposes of 4,000 Common Shares Worth $330,640

Reuters
·
Aug 05

Gartner Inc. Stock Climbs 22.6%, Outperforms Peers

Dow Jones
·
Aug 05

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

THOMSON REUTERS
·
Aug 05

Analysts’ Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)

TIPRANKS
·
Aug 04

Oscar Health Inc Expected to Post Earnings of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Tempus AI announces study results of PRISM2

TIPRANKS
·
Aug 04

Tempus AI Inc : Btig Cuts Target Price to $70 from $80

THOMSON REUTERS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 04

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

TIPRANKS
·
Aug 04

THRIVE Trial Puts IQVIA in Focus as Renal Denervation Race Heats Up

TIPRANKS
·
Aug 04

Tempus AI is Maintained at Hold by Stifel

Dow Jones
·
Aug 03

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

TIPRANKS
·
Aug 01

DexCom (DXCM) Stock Surges On Margin Strength And Raised Outlook

Simply Wall St.
·
Aug 01

Top IQVIA Insiders Quietly Unload Millions in Company Stock

TIPRANKS
·
Aug 01

IQVIA CEO Ari Bousbib Disposes of Common Shares Worth $26.23 Million

Reuters
·
Aug 01